Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, Mackensen A, Wullich B, Maas R, Fromm M, Geßner A, Verena Taudte R (2021)
Publication Language: English
Publication Type: Journal article
Publication year: 2021
Book Volume: 13
Article Number: 6329
Journal Issue: 24
Oral anticancer drugs have led to significant improvements in the treatment of multiple tumor entities. However, in patients undergoing oral antitumor therapy, plasma concentrations are highly variable, resulting in risks of reduced therapeutic effects or an increase in side effects. One important tool to reduce this variability is therapeutic drug monitoring. In this work we describe a method to simultaneously quantify the plasma concentrations of 57 oral antitumor agents. Quantification of these drugs was achieved using liquid chromatography coupled to an Orbitrap mass spectrometer. The method was fully validated according to the FDA guidelines and constitutes a simple and robust way for exposure monitoring of a wide variety of oral anticancer drugs. Applicability to clinical routine was demonstrated by the analysis of 71 plasma samples taken from 39 patients. In summary, this new multi-drug method allows simultaneous quantification of 57 oral antitumor drugs, which can be applied to exposure monitoring in clinical studies, taking into account the broad variety of oral antitumor drugs prescribed in clinical routine.
APA:
Kehl, N., Schlichtig, K., Dürr, P., Bellut, L., Dörje, F., Fietkau, R.,... Verena Taudte, R. (2021). An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma. Cancers, 13(24). https://doi.org/10.3390/cancers13246329
MLA:
Kehl, Niklas, et al. "An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma." Cancers 13.24 (2021).
BibTeX: Download